Tumor consistency in cancer diagnosis
Pro Research Analysisby 
Searched over 200M research papers
Tumor Consistency in Cancer Diagnosis: Importance and Assessment Methods
Tumor Consistency and Its Role in Cancer Diagnosis
Tumor consistency—whether a tumor is soft, intermediate, or hard—plays a crucial role in cancer diagnosis, surgical planning, and predicting treatment outcomes. Consistency can affect the ease of surgical resection and is often linked to the tumor’s collagen content and invasiveness, especially in central nervous system (CNS) tumors like pituitary adenomas and meningiomas Ding2021Fiore2023Koechli2023.
Imaging and Radiomics for Predicting Tumor Consistency
Advanced imaging techniques, such as diffusion-weighted imaging (DWI) and radiomics, are increasingly used to predict tumor consistency before surgery. Studies show that the apparent diffusion coefficient (ADC) ratio from DWI correlates with tumor collagen content and can reliably predict whether a pituitary adenoma is soft, intermediate, or hard. This information helps surgeons plan the extent of resection and anticipate surgical challenges Ding2021Fiore2023. Radiomics and machine learning models have also demonstrated promising accuracy (AUC 0.71–0.99) in predicting the consistency of benign CNS tumors, though external validation and standardized practices are still needed for broader clinical adoption .
Consistency in Tumor Classification and Subtyping
Consistency in tumor classification is vital for accurate diagnosis and treatment selection. For example, in breast cancer, improved algorithms like PCA-PAM50 have increased the agreement between gene expression-based intrinsic subtyping and traditional clinical subtyping, leading to more precise classification and better patient stratification for therapy . However, challenges remain in certain areas, such as distinguishing HER2-null from HER2-ultralow breast cancers, where interobserver consistency among pathologists is low. This inconsistency can impact patient eligibility for targeted therapies, highlighting the need for improved detection methods and AI-assisted assessments .
Consistency in Molecular and Genetic Testing
In non-small cell lung cancer (NSCLC), the consistency between circulating tumor DNA (ctDNA)-based and tissue-based next-generation sequencing (NGS) is important for identifying actionable mutations. Studies show that ctDNA-based NGS has comparable performance to tissue-based NGS, especially in advanced or metastatic cases, making it a suitable alternative when tissue samples are hard to obtain . However, meta-analyses reveal that the consistency of mutation detection can vary depending on the gene type and sample size, with higher heterogeneity observed in studies focusing on EGFR mutations and in larger sample groups .
Consistency in Pathology and Digital Image Analysis
Consistency in pathological assessment is essential for reliable cancer diagnosis. For example, digital image analysis (DIA) of tumor-infiltrating lymphocytes (TILs) in triple-negative breast cancer has shown high reproducibility among pathologists, reducing variation caused by tumor heterogeneity . In contrast, traditional pathology-based tumor classification can suffer from lower consistency, especially in complex or borderline cases, underscoring the value of digital and AI-assisted methods Zhou2024Wu2025.
Consistency in Cancer Surveillance and Registry Data
High-quality cancer registry data depend on consistent tumor diagnosis and coding. Studies of brain tumor registries show high concordance rates for nonmalignant tumors, but lower rates for malignant and mixed gliomas. Accurate and consistent coding is crucial for reliable cancer surveillance and epidemiological studies .
Conclusion
Tumor consistency is a key factor in cancer diagnosis, influencing surgical planning, treatment selection, and the reliability of cancer surveillance data. Advances in imaging, radiomics, molecular testing, and digital pathology are improving the consistency and accuracy of tumor assessment. However, challenges remain in standardizing methods and ensuring reproducibility, especially in complex diagnostic scenarios. Continued development and validation of new technologies and algorithms are essential for enhancing consistency in cancer diagnosis and improving patient outcomes.
Sources and full results
Most relevant research papers on this topic